ICAP’s Jessica Justman, MD, senior technical director, remains hopeful in the potential benefits of convalescent plasma as treatment for patients with COVID-19. She recently spoke to NPR on the role the treatment could play in the global pandemic response:

“What I like about the convalescent plasma idea is that if it worked, I see it as something that could really be scalable in resource-limited settings. And I think that’s where convalescent plasma has this really great potential.”

Read the full story on NPR

Read the latest ICAP updates on COVID-19 here

Related Items